CWS Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $300K | Buy |
2,702
+855
| +46% | +$94.8K | 0.09% | 110 |
|
|
2025
Q1 | $207K | Buy |
+1,847
| New | +$207K | 0.07% | 125 |
|
|
2024
Q2 | – | Sell |
-3,767
| Closed | -$276K | – | 107 |
|
|
2024
Q1 | $276K | Sell |
3,767
-3,388
| -47% | -$248K | 0.11% | 89 |
|
|
2023
Q4 | $580K | Sell |
7,155
-369
| -5% | -$29.9K | 0.22% | 68 |
|
|
2023
Q3 | $564K | Sell |
7,524
-6
| -0.1% | -$450 | 0.23% | 67 |
|
|
2023
Q2 | $580K | Sell |
7,530
-143
| -2% | -$11K | 0.22% | 69 |
|
|
2023
Q1 | $637K | Buy |
7,673
+197
| +3% | +$16.3K | 0.25% | 65 |
|
|
2022
Q4 | $483K | Sell |
7,476
-700
| -9% | -$45.2K | 0.21% | 74 |
|
|
2022
Q3 | $504K | Buy |
8,176
+70
| +0.9% | +$4.32K | 0.24% | 72 |
|
|
2022
Q2 | $501K | Sell |
8,106
-881
| -10% | -$54.5K | 0.23% | 80 |
|
|
2022
Q1 | $534K | Buy |
8,987
+90
| +1% | +$5.35K | 0.2% | 81 |
|
|
2021
Q4 | $646K | Buy |
+8,897
| New | +$646K | 0.23% | 74 |
|
|
2021
Q2 | $514K | Sell |
7,469
-7
| -0.1% | -$482 | 0.2% | 75 |
|
|
2021
Q1 | $483K | Buy |
7,476
+75
| +1% | +$4.85K | 0.21% | 74 |
|
|
2020
Q4 | $431K | Sell |
7,401
-263
| -3% | -$15.3K | 0.25% | 73 |
|
|
2020
Q3 | $484K | Sell |
7,664
-61
| -0.8% | -$3.85K | 0.32% | 64 |
|
|
2020
Q2 | $594K | Buy |
7,725
+1,353
| +21% | +$104K | 0.43% | 50 |
|
|
2020
Q1 | $414K | Hold |
6,372
| – | – | 0.31% | 74 |
|
|
2019
Q4 | $414K | Buy |
+6,372
| New | +$414K | 0.3% | 75 |
|